Abstract:Objective:To investigate the expression and biological function of Human endogenous retrovirus subfamily H long terminal repeat associating protein 2 (HHLA2) in human non-small cell lung cancer (NSCLC) cell lines A549, H1975, and SK-MES-1.Methods:We used The Cancer Genome Atlas (TCGA) database to analyze HHLA2 mRNA expression′s prognostic value in NSCLC tissue by Log-rank test. Human NSCLC cell line with stable down-regulation of HHLA2 expression was constructed by RNA interference (RNAi) technique. The effect of down-regulation of HHLA2 expression on the biological function of human NSCLC cell line was observed by cell proliferation assay, wound healing assay and transwell invasion assay, and the comparison between groups was analyzed by t-test. Results:TCGA database results showed that the overall survival (OS) of patients with lung cancer with low expression of HHLA2 mRNA was significantly higher than that of patients with high expression of HHLA2 mRNA (Lung adenocarcinoma: Log-rank P=0.082, Lung squamous cell carcinoma: Log-rank P=0.022). The functional enrichment analysis showed that HHLA2 might be related to the proliferation, migration, and invasion ability of NSCLC cells. The results of Real-time polymerase chain reaction (Real-time PCR) and Western blotting showed that the expression levels of HHLA2 mRNA and protein in LV-shHHLA2 group were significantly lower than those in LV-NC group. Cell Counting Kit-8 (CCK-8) assay showed that down-regulation of HHLA2 expression could significantly reduce the proliferation ability of the three types of cells (A549: 48 h: 0.475±0.014 vs. 0.600±0.030, t=3.813, P<0.05; 72 h: 0.658±0.044 vs. 0.911±0.039, t=4.336 P<0.05; H1975: 48 h: 0.414±0.026 vs. 0.550±0.026, t=3.669, P<0.05; 72 h: 0.645±0.049 vs. 0.926±0.026, t=5.076, P<0.01; SK-MES-1: 48 h: 0.387±0.043 vs. 0.606±0.037, t=3.870, P<0.05; 72 h: 0.675±0.044 vs. 0.971±0.045, t=4.717, P<0.01). Wound healing assay showed that down-regulation of HHLA2 expression could significantly reduce the migration ability of the three types of cells (A549: 0.489±0.046 vs. 1.000±0.033, t=8.975, P<0.001; H1975: 0.242±0.060 vs. 1.000±0.028, t=11.390, P<0.001; SK-MES-1: 0.403±0.071 vs. 1.000±0.092, t=5.150, P<0.001). Transwell invasion assay showed that down-regulation of HHLA2 expression could significantly reduce the invasion ability of the three types of cells (A549: 150.333±7.881 vs. 226.000±6.429, t=7.440 P<0.01; H1975: 92.000±11.790 vs. 203.333±7.839, t=7.864, P<0.01; SK-MES-1: 95.333±14.881 vs. 201.000±16.643, t=4.733, P<0.01). Conclusion:Interfering with the expression of HHLA2 in NSCLC cells can reduce the ability of proliferation, migration, and invasion.

ARNT2 is Downregulated and Serves As a Potential Tumor Suppressor Gene in Non-Small Cell Lung Cancer

Downregulation of ARNT2 Promotes Tumor Growth and Predicts Poor Prognosis in Human Hepatocellular Carcinoma

Upregulation of ARNTL2 is Associated with Poor Survival and Immune Infiltration in Clear Cell Renal Cell Carcinoma

Overexpression of ARNT2 is Associated with Decreased Cell Proliferation and Better Prognosis in Gastric Cancer

Upregulation of ARNTL2 Predicts Poor Survival for Clear Cell Renal Cell Carcinoma and Explores Its Associations with PD-L1 and Immune Infiltration

ARNTL2 is an Indicator of Poor Prognosis, Promotes Epithelial-to-mesenchymal Transition and Inhibits Ferroptosis in Lung Adenocarcinoma

Targeting the ARNTL2 Gene as a Potential Strategy for Lung Adenocarcinoma

Aryl Hydrocarbon Receptor Nuclear Translocator is Associated with Tumor Growth and Progression of Hepatocellular Carcinoma

Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma

The circadian rhythm key gene ARNTL2: a novel prognostic biomarker for immunosuppressive tumor microenvironment identification and immunotherapy outcome prediction in human cancers

Activating Transcription Factor 2 Expression Mediates Cell Proliferation and is Associated with Poor Prognosis in Human Non-Small Cell Lung Carcinoma.

The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment

ARNTL2 upregulation of ACOT7 promotes NSCLC cell proliferation through inhibition of apoptosis and ferroptosis

The promotion of cell proliferation and invasion in cutaneous squamous cell carcinomas after ARNT downregulation is associated with CXCL3

Low Expression of Long Noncoding RNA CASC2 Indicates a Poor Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer

Human endogenous retrovirus subfamily H long terminal repeat associating protein 2 expression and its biological function in human non-small cell lung cancer cell lines

Diagnostic and Prognostic Value of Serum Angiopoietin-Like Protein 2 in Patients with Non-Small Cell Lung Cancer

[Effects of ARNT2 Gene on Invasion and Migration of Human Hepatocellular Carcinoma HCCLM6 Cell Line].

Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells

The Effects and Mechanisms of SLC34A2 in Tumorigenesis and Progression of Human Non-Small Cell Lung Cancer

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer